J. Safra Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.7K Sell
64
-26
-29% -$8.54K ﹤0.01% 311
2025
Q4
$31.6K Buy
+90
New +$30.4K ﹤0.01% 302
2023
Q3
Sell
-55
Closed -$24.4K 111
2023
Q2
$24.4K Hold
55
﹤0.01% 92
2023
Q1
$25.3K Buy
+55
New +$26.2K ﹤0.01% 93

Other funds holding ELV

J. Safra Asset Management's ELV Position: Q1 2026 in Review

J. Safra Asset Management reduced its Elevance Health (ELV) stake by 29% in Q1 2026, selling an estimated $8.54K and leaving 64 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #311.

J. Safra Asset Management first reported a position in ELV in Q1 2023 and has held it in 4 quarters since. The position peaked at $31.6K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • J. Safra Asset Management held 64 shares of Elevance Health worth $18.7K as of Q1 2026.
  • J. Safra Asset Management sold 26 Elevance Health shares in Q1 2026, an estimated $8.54K.
  • Elevance Health made up ﹤0.01% of J. Safra Asset Management's portfolio in Q1 2026, its #311 holding.
  • J. Safra Asset Management first reported a position in Elevance Health in Q1 2023 and has held it in 4 quarters since.
  • J. Safra Asset Management's Elevance Health position peaked at $31.6K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.